A dual cardiomyocyte reporter model derived from human pluripotent stem cells
Yuqian Jiang1, Xiaoping Bao2, Xiaojun Lance Lian3,4,5
1Department of Biomedical Engineering, Pennsylvania State University, University Park, PA, 16802, USA.
Insights
Researchers developed a new human pluripotent stem cell (hPSC) line to isolate and study cardiomyocytes (CMs). This dual reporter system aids in cardiovascular disease (CVD) research and drug discovery.
Area of Science:
- Stem cell biology
- Cardiovascular research
- Biotechnology
Background:
- Cardiovascular diseases (CVD) are a major cause of mortality.
- Human pluripotent stem cells (hPSCs) offer potential for regenerative medicine, disease modeling, and drug screening.
- Efficient methods for isolating and characterizing cardiomyocytes (CMs) are crucial for these applications.
Purpose of the Study:
- To establish a novel human pluripotent stem cell (hPSC) line for the purification and characterization of cardiomyocytes (CMs).
- To create a dual reporter system for enhanced CM analysis.
- To facilitate advancements in cardiovascular disease (CVD) modeling and drug discovery.
Main Methods:
- Generation of an hPSC line with a mCherry fluorescent protein reporter under the alpha myosin heavy chain (aMHC) promoter.
- Integration of a fluorescent voltage indicator (ASAP2f) for dual-color imaging.
- Utilizing fluorescence to purify and characterize CM subtypes.
Main Results:
- Successful establishment of a dual reporter hPSC line enabling CM purification via aMHC promoter activity.
- Demonstration of the platform's capability for characterizing CM subtypes.
- Validation of the dual reporter system for potential use in CVD research.
Conclusions:
- The developed dual reporter hPSC platform provides a robust tool for cardiomyocyte purification and characterization.
- This system holds significant promise for advancing cardiovascular disease modeling and therapeutic discovery.
- The technology enables precise analysis of cardiomyocyte subtypes for targeted research.
Abstract:
Cardiovascular diseases (CVD) remain the leading cause of death in the USA. Cardiomyocytes (CMs) derived from human pluripotent stem cells (hPSCs) provide a valuable cell source for regenerative therapy, disease modeling, and drug screening. Here, we established a hPSC line integrated with a mCherry fluorescent protein driven by the alpha myosin heavy chain (aMHC) promoter, which could be used to purify CMs based on the aMHC promoter activity in these cells. Combined with a fluorescent voltage indicator, ASAP2f, we achieved a dual reporter CM platform, which enables purification and characterization of CM subtypes and holds great potential for disease modeling and drug discovery of CVD.
More Related Videos
11:13Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes hPSC-CMs Using Multi-electrode Arrays MEAs
Published on: May 12, 2017
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
